These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
884 related articles for article (PubMed ID: 29762873)
1. L-ornithine L-aspartate for prevention and treatment of hepatic encephalopathy in people with cirrhosis. Goh ET; Stokes CS; Sidhu SS; Vilstrup H; Gluud LL; Morgan MY Cochrane Database Syst Rev; 2018 May; 5(5):CD012410. PubMed ID: 29762873 [TBL] [Abstract][Full Text] [Related]
2. Pharmacotherapies that specifically target ammonia for the prevention and treatment of hepatic encephalopathy in adults with cirrhosis. Zacharias HD; Zacharias AP; Gluud LL; Morgan MY Cochrane Database Syst Rev; 2019 Jun; 6(6):CD012334. PubMed ID: 31204790 [TBL] [Abstract][Full Text] [Related]
3. Non-absorbable disaccharides versus placebo/no intervention and lactulose versus lactitol for the prevention and treatment of hepatic encephalopathy in people with cirrhosis. Gluud LL; Vilstrup H; Morgan MY Cochrane Database Syst Rev; 2016 May; 2016(5):CD003044. PubMed ID: 27153247 [TBL] [Abstract][Full Text] [Related]
4. Non-absorbable disaccharides versus placebo/no intervention and lactulose versus lactitol for the prevention and treatment of hepatic encephalopathy in people with cirrhosis. Gluud LL; Vilstrup H; Morgan MY Cochrane Database Syst Rev; 2016 Apr; 4():CD003044. PubMed ID: 27089005 [TBL] [Abstract][Full Text] [Related]
5. Rifaximin for prevention and treatment of hepatic encephalopathy in people with cirrhosis. Zacharias HD; Kamel F; Tan J; Kimer N; Gluud LL; Morgan MY Cochrane Database Syst Rev; 2023 Jul; 7(7):CD011585. PubMed ID: 37467180 [TBL] [Abstract][Full Text] [Related]
6. Branched-chain amino acids for people with hepatic encephalopathy. Gluud LL; Dam G; Les I; Marchesini G; Borre M; Aagaard NK; Vilstrup H Cochrane Database Syst Rev; 2017 May; 5(5):CD001939. PubMed ID: 28518283 [TBL] [Abstract][Full Text] [Related]
7. Flumazenil versus placebo or no intervention for people with cirrhosis and hepatic encephalopathy. Goh ET; Andersen ML; Morgan MY; Gluud LL Cochrane Database Syst Rev; 2017 Jul; 7(7):CD002798. PubMed ID: 28745801 [TBL] [Abstract][Full Text] [Related]
8. Flumazenil versus placebo or no intervention for people with cirrhosis and hepatic encephalopathy. Goh ET; Andersen ML; Morgan MY; Gluud LL Cochrane Database Syst Rev; 2017 Aug; 8(8):CD002798. PubMed ID: 28796283 [TBL] [Abstract][Full Text] [Related]
9. Branched-chain amino acids for people with hepatic encephalopathy. Gluud LL; Dam G; Les I; Córdoba J; Marchesini G; Borre M; Aagaard NK; Vilstrup H Cochrane Database Syst Rev; 2015 Feb; (2):CD001939. PubMed ID: 25715177 [TBL] [Abstract][Full Text] [Related]
10. Branched-chain amino acids for people with hepatic encephalopathy. Gluud LL; Dam G; Les I; Córdoba J; Marchesini G; Borre M; Aagaard NK; Vilstrup H Cochrane Database Syst Rev; 2015 Sep; (9):CD001939. PubMed ID: 26377410 [TBL] [Abstract][Full Text] [Related]
11. Acetyl-L-carnitine for patients with hepatic encephalopathy. Martí-Carvajal AJ; Gluud C; Arevalo-Rodriguez I; Martí-Amarista CE Cochrane Database Syst Rev; 2019 Jan; 1(1):CD011451. PubMed ID: 30610762 [TBL] [Abstract][Full Text] [Related]
12. Probiotics for people with hepatic encephalopathy. Dalal R; McGee RG; Riordan SM; Webster AC Cochrane Database Syst Rev; 2017 Feb; 2(2):CD008716. PubMed ID: 28230908 [TBL] [Abstract][Full Text] [Related]
14. Carvedilol versus traditional, non-selective beta-blockers for adults with cirrhosis and gastroesophageal varices. Zacharias AP; Jeyaraj R; Hobolth L; Bendtsen F; Gluud LL; Morgan MY Cochrane Database Syst Rev; 2018 Oct; 10(10):CD011510. PubMed ID: 30372514 [TBL] [Abstract][Full Text] [Related]
15. Terlipressin versus placebo or no intervention for people with cirrhosis and hepatorenal syndrome. Allegretti AS; Israelsen M; Krag A; Jovani M; Goldin AH; Schulman AR; Winter RW; Gluud LL Cochrane Database Syst Rev; 2017 Jun; 6(6):CD005162. PubMed ID: 29943803 [TBL] [Abstract][Full Text] [Related]
16. Plasma expanders for people with cirrhosis and large ascites treated with abdominal paracentesis. Simonetti RG; Perricone G; Nikolova D; Bjelakovic G; Gluud C Cochrane Database Syst Rev; 2019 Jun; 6(6):CD004039. PubMed ID: 31251387 [TBL] [Abstract][Full Text] [Related]
17. Radix Sophorae flavescentis versus no intervention or placebo for chronic hepatitis B. Liang N; Kong Z; Ma SS; Lu CL; Yang M; Feng LD; Shen C; Diao RH; Cui LJ; Lu XY; Nikolova D; Jakobsen JC; Gluud C; Liu JP Cochrane Database Syst Rev; 2019 Apr; 4(4):CD013089. PubMed ID: 30941748 [TBL] [Abstract][Full Text] [Related]
18. Vitamin D supplementation for chronic liver diseases in adults. Bjelakovic G; Nikolova D; Bjelakovic M; Gluud C Cochrane Database Syst Rev; 2017 Nov; 11(11):CD011564. PubMed ID: 29099543 [TBL] [Abstract][Full Text] [Related]